{"database": "lobbying", "table": "lobbying_activities", "rows": [[2101604, "bbc93648-c4b8-4d91-896d-3c6dcb937ff8", "Q1", "HOLLAND & KNIGHT LLP", 18466, "THE BIOSIMILARS FORUM", 2018, "first_quarter", "MMM", "Medicare reimbursement issues, FDA regulation of biosimilars; H.R. 1625, Consolidated Appropriations Act of 2018.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 0, "2018-04-02T14:15:27.313000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2101604"], "units": {}, "query_ms": 0.33798906952142715, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}